Literature DB >> 8627819

Characterization of long-term cultures of hepatitis C virus.

N Nakajima1, M Hijikata, H Yoshikura, Y K Shimizu.   

Abstract

The human T- and B-cell lines HPBMa10-2 and Daudi produced infectious hepatitis C virus (HCV) for more than 1 year after infection. The infectivity titer of the cell culture-grown HCV and its genome titer were comparable. The virion density in sucrose was around 1.12 g/ml. Among the 13 variants detected in the inoculum, 7 were adsorbed by the cells and one particular HCV sequence which was present in minor quantities in the inoculum persisted.

Entities:  

Mesh:

Year:  1996        PMID: 8627819      PMCID: PMC190202     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Early events in hepatitis C virus infection of chimpanzees.

Authors:  Y K Shimizu; A J Weiner; J Rosenblatt; D C Wong; M Shapiro; T Popkin; M Houghton; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Association of hepatitis C virus in human sera with beta-lipoprotein.

Authors:  R Thomssen; S Bonk; C Propfe; K H Heermann; H G Köchel; A Uy
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

4.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

Authors:  G Inchauspe; S Zebedee; D H Lee; M Sugitani; M Nasoff; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose.

Authors:  D Bradley; K McCaustland; K Krawczynski; J Spelbring; C Humphrey; E H Cook
Journal:  J Med Virol       Date:  1991-07       Impact factor: 2.327

6.  Non-A, non-B hepatitis in chimpanzees and marmosets.

Authors:  S M Feinstone; H J Alter; H P Dienes; Y Shimizu; H Popper; D Blackmore; D Sly; W T London; R H Purcell
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.

Authors:  N Kato; T Nakazawa; T Mizutani; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

9.  Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.

Authors:  Y K Shimizu; A Iwamoto; M Hijikata; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Thermostability of human immunodeficiency virus (HIV-1) in a liquid matrix is far higher than that of an ecotropic murine leukemia virus.

Authors:  H Yoshikura
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  24 in total

1.  Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees.

Authors:  Y K Shimizu; H Igarashi; T Kanematu; K Fujiwara; D C Wong; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The hepatitis C virus 5'UTR genomic region remains highly conserved under HAART: a 4- to 8-year longitudinal study from HCV/HIV co-infected patients.

Authors:  Franco Moretti; Federico Bolcic; Lilia Mammana; Maria Belen Bouzas; Natalia Laufer; Jorge Quarleri
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

3.  Hepatitis C virus infection of human hepatoma cell line 7721 in vitro.

Authors:  Z Q Song; F Hao; F Min; Q Y Ma; G D Liu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

4.  Specific interaction of a 25-kilodalton cellular protein, a 40S ribosomal subunit protein, with the internal ribosome entry site of hepatitis C virus genome.

Authors:  S Fukushi; M Okada; T Kageyama; F B Hoshino; K Katayama
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.

Authors:  H Lerat; Y K Shimizu; S M Lemon
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Authors:  Yi-Ping Li; Santseharay Ramirez; Lotte Mikkelsen; Jens Bukh
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 7.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

8.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

10.  Occult persistence and lymphotropism of hepatitis C virus infection.

Authors:  Tram-Nq Pham; Tomasz-I Michalak
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.